Table 2.
Co-expression ratios of HAP1/nociceptive markers and nociceptive markers/HAP1 in the different levels of mouse DRG.
| Relationship of HAP1 with different markers (ratio %) | Cervical | Thoracic | Lumbar | Sacral | |
|---|---|---|---|---|---|
| SP | HAP1/SP | 71.12 ± 4.3 | 75.91 ± 6.3 | 71.91 ± 9.8 | 72.91 ± 4.1 |
| SP/HAP1 | 55.43 ± 5.5 | 56.59 ± 8.1 | 60.12 ± 7.4 | 62.27 ± 7.6 | |
| CGRP | HAP1/CGRP | 84.71 ± 6.2 | 82.76 ± 9.4 | 85.76 ± 3.3 | 78.34 ± 5.2 |
| CGRP/HAP1 | 68.64 ± 8.3 | 74.21 ± 6.2 | 75.31 ± 9.1 | 69.75 ± 7.5 | |
| CB | HAP1/CB | 80.39 ± 6.1 | 82.61 ± 3.2 | 91.83 ± 4.2 | 89.32 ± 2.8 |
| CB/HAP1 | 58.56 ± 9.1 | 63.33 ± 8.5 | 67.78 ± 7.1 | 71.23 ± 7.3 | |
| NOS | HAP1/NOS | 75.67 ± 8.2 | 81.25 ± 7.5 | 87.43 ± 6.2 | 85.33 ± 4.1 |
| NOS/HAP1 | 35.56 ± 5.2 | 40.64 ± 2.8 | 44.75 ± 9.1 | 39.14 ± 7.2 | |
| TRPV1 | HAP1/TRPV1 | 70.36 ± 6.9 | 78.57 ± 2.5 | 79.39 ± 4.1 | 81.48 ± 5.6 |
| TRPV1/HAP1 | 52.34 ± 7.4 | 57.12 ± 8.3 | 61.34 ± 9.1 | 56.89 ± 3.5 | |
Values represent the mean ± SEM (n = 6). CB, calbindin; CGRP, calcitonin gene-related peptide; NOS, nitric oxide synthetase; SP, substance P; TRPV1, transient receptor potential vanilloid 1.